In this issue of Blood, Lerman et al¹ identify the α3β1 integrin as a novel marker for hyperactivated neutrophils in septic patients and septic mice and provide functional evidence that this integrin contributes significantly to neutrophil infiltration and hyperresponsiveness in sepsis. Thus, α3β1 integrin could represent a novel and specific therapeutic target for sepsis.